Welcome to CoffyLaw
Whether you’re protecting your right to benefit from something you’ve created or are looking to provide your loved ones the best chance at a successful future, skilled legal counsel gives you an advantage. At CoffyLaw, LLC, our boutique firm’s technical acumen rivals that of a large firm while delivering responsive, personalized service in a small-office setting.
When we acquired our company, we obtained a client distribution list as part of the deal. WE kept the same delivery driver. After a few months, we realized the driver was consigning with a competitor to distribute our product. We contacted Emmanuel Coffy who informed us that a “client distribution list” may be proprietary information deserving of protection. Mr. Coffy diligently took the proper course of action to protect our client distribution list……..Iverson L.
Emmanuel Coffy drafted my patent application which was quickly issued. Some fie years later when an office action was issued against the another application, I searched for and found Emmanuel to draft the response for me. I was confident he would do the best job……David F.
When we applied for a trademark, a competitor instituted an opposition proceeding against us. We chose CoffyLaw to represent us, because the firm was the most knowledgeable and cost effective among the other firms we consulted……Paul M.
I had an idea I needed to protect. Not knowing where to turn, I was drawn to an organization that was featured through TV advertising. Bought in. After a substantial deposit and retainer totaling more than $10,000 and a long waiting period, I was totally dissatisfied with the results. I was later introduced to Emmanuel Coffy. He expeditiously obtained my design patent for a fraction of the cost. I’m now the proud inventor of a design patent…..Michaela W.
Fritzner L. Altidor, Esq. CPA
US Federal Court Of Appeals For The Federal Circuit
Swedish company issues statement after an unsourced Chinese media article claims that a probe into its licensing practices is underway
SPC disputes, second medical use issues, pharma UPC strategies, CRISPR and much more from IAM’s third annual pharma and biotech IP conference, which took place in London earlier this week
Delaware lawsuit is first move to litigate assets since former RPX dealmaker took control of portfolio
Brand name pharmaceutical companies are facing a policy-making onslaught; with their IP strategies firmly in the spotlight, many are being forced to speak up for the rights that underpin their products.
America’s life sciences innovators face accusations of using patents to build monopolies and overcharge for vital medicines. If they do not tell their side of the story and fast, they risk losing vital protections on which they rely
After Microsoft’s headline grabbing decision to sign-up to the network last year, LOT CEO “absolutely expects IBM to join” once its Red Hat acquisition is finalised
Microsoft and Alphabet possess the strongest machine learning portfolios, but Chinese state-sponsored R&D and access to data has the potential to shift the power dynamics
The Asia IP Elite identifies companies and institutions in the region that have world class IP functions. Here we introduce the 18 latest additions and explain why they have made the cut
IP office director states that even TSMC, the island’s top patentee, relies on trade secrets to protect 90% of innovations
Your essential Sunday reading: a summary of all the stories posted on the IAM platform in the past week – as well as links to each one